Cargando…
Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study
BACKGROUND: S-1 adjuvant chemotherapy is the standard treatment in Asia for resectable pancreatic ductal adenocarcinoma. The relative dose intensity of adjuvant chemotherapy influences survival in pancreatic cancer but does not precisely reflect treatment schedule modifications. We investigated the...
Autores principales: | Kobayashi, Kazuki, Einama, Takahiro, Takihata, Yasuhiro, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Kouzu, Keita, Nakazawa, Akiko, Iwasaki, Toshimitsu, Ueno, Hideki, Kishi, Yoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524130/ https://www.ncbi.nlm.nih.gov/pubmed/36180830 http://dx.doi.org/10.1186/s12885-022-10116-2 |
Ejemplares similares
-
Clinical Impact of Dual Time Point (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer
por: Einama, Takahiro, et al.
Publicado: (2022) -
Prognosis of Pancreatic Cancer Based on Resectability: A Single Center Experience
por: Einama, Takahiro, et al.
Publicado: (2023) -
Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma
por: Takihata, Yasuhiro, et al.
Publicado: (2021) -
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients
por: Einama, Takahiro, et al.
Publicado: (2021) -
A rare case of isolated splenic sarcoidosis: A case report and literature review
por: Kobayashi, Kazuki, et al.
Publicado: (2021)